Rapid COVID-19 guidance on vitamin D
In collaboration with Public Health England and the Scientific Advisory Committee on Nutrition, NICE has published rapid guidance on vitamin D in relation to COVID-19. This supports current government advice for everyone to take a 10 microgram (400IU) vitamin D supplement every day throughout the autumn and winter. This dose is safe and effective at maintaining vitamin D levels. Vitamin D is important for bone and muscle health.
Many people have been indoors more than usual this spring and summer, which means they might not have been making enough vitamin D from sunlight. Some people are more at risk of not receiving enough Vitamin D even in spring and summer and this includes those with dark skin (such as those with African, Afro-Caribbean or South Asian backgrounds), those who are not outside very often, people in care homes and those who cover up most of their skin when they are outside. It is advised that these people take a vitamin D supplement all year round.
Clinically vulnerable groups will also be eligible for free vitamin D supplement throughout the winter, starting in January 2021. There are 2.7 million vulnerable people in England who will be offered free vitamin D supplements including automatic deliveries to all care homes for their residents and letters will be sent to clinically extremely vulnerable people (as designated during the pandemic) inviting them to opt-in for a 4 month supply to be delivered directly to their homes.
The guidance also concluded that there is currently not enough reliable evidence to support taking vitamin D solely to prevent or treat COVID-19. The NICE guidance recommends that more research needs to be conducted on the subject and stresses the use of high-quality randomised controlled trials in future studies. The guidance can be found by visiting:
Final Guidance for Type 1 diabetes and Type 2 diabetes in children and young people
This final guideline has now been published on the NICE website. You can also find the supporting evidence, tools and resources as well as all the stakeholder comments and responses that we made during consultation.
The recommendations from this guideline have been included in the NICE Pathways on Diabetes in children and young people and Bedwetting in children and young people, which bring together everything NICE has said on Diabetes (type 1 and type 2) in children and young people: diagnosis and management in interactive flowcharts. There is brief information about the guideline for people using services, carers and the public at ‘Information for the public’. The links are as follows:
NICE guideline on Diabetes in pregnancy: management from preconception to the postnatal period
This final guideline has now been published on the NICE website: https://www.nice.org.uk/guidance/ng3 Again, you can also find the supporting evidence, tools and resources as well as all the stakeholder comments that were received during consultation.
The recommendations from this guideline have been included in the NICE Pathway on Diabetes in Pregnancy, which brings together everything NICE has said on Diabetes in pregnancy: management from preconception to the postnatal period in an interactive flowchart. There is brief information about the guideline for people using services, carers and the public. The links are as follows: